4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-15-019730
CIK 0001328143operating
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:24 PM ET
Size
9.1 KB
Accession
0001209191-15-019730
Insider Transaction Report
Form 4
Knapp Jeffrey H
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2015-02-25+65,000→ 65,000 totalExercise: $17.31Exp: 2025-02-24→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with March 1, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:24 PM ET
- Size
- 9.1 KB